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Transcatheter occlusion of atrial septal defects with the buttoned device has been reported by investigators from several ~enters.l-~ Although transesophageal echocardiographic (TEE) guidance has proved to be very important in implanting the Clamshell occlusion device: the role of echocardiographic guidance in implanting the buttoned device has not been studied. We therefore reviewed our experience with the buttoned device to determine whether TEE guidance favorably influenced device positioning or clinical complications as compared to transthoracic echocardiographic (TTE) guidance.
Methods
Records of all patients who underwent attempted transcatheter closure of secundum atrial septal defects with the buttoned device (Custom Medical Devices, Amarillo, TX, USA)
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Address for correspondence and reprints: Thomas R. Lloyd were excluded: the procedure was abandoned without implanting a device in six patients; and TTE was inadequate to definitively indicate the position of all six device arms in one adolescent patient with Marfan's syndrome and pectus excavatum. Results from the remaining 34 patients are shown in Table I . TTE was used in 23 patients and TEE in 11 patients. Ideal device position was defined as all four occluder arms on the left atrial side of the septum, both counteroccluder arms on the right atrial side of the septum, and no impingement by the device on any structures beyond the atrial septum (Fig. 1) . Ideal position was observed in 17 cases (50%). In 13 cases, one or two occluder arms passed through the defect into the right atrium (Fig. 2) . In three cases, an occluder arm extended to the mitral valve, and a counteroccluder arm extended to the tricuspid valve in two cases (both cases have occluder arms in the right atrium). In the remaining patient, a counteroccluder arm extended into the inferior vena cava. Of the 11 devices implanted under TEE guidance, ten were in ideal position. Only 7 of 23 devices implanted under TTE guidance were in ideal position (P = 0.001). Small-to-moderate residual left-to-right shunts (shunt fraction 0.20-0.33) were present in five patients immediately after occlusion, including four patients with occluder arms positioned in the right atrium and one patient whose device met the criteria for ideal placement. Unbuttoning of four devices occurred, three with occluder arms in the right atrium and one thought to be in ideal position. Combining the clinically significant and potentially significant complicating factors of unbuttoning, small-to-moderate residual shunts, and arm placement on atrioventricular valve apparatus, these factors were present in 3 of ll patients in whom TEE guidance was used, compared to 10 of 23 TTE patients (P = 0.30). When analyzed by device position, only 2 of 17 patients with ideal device position have these factors, compared to 11 of 17 patients with nonideal device position (P = 0.002).
Discussion
The buttoned device was designed to be implanted without need for echocardiographic guidan~e.~ In our initial experience, we found both TTE and TEE guidance helpful in balloon sizing of the defects and in confirming device position and efficacy.* The present retrospective comparison suggests that TEE guidance is associated with more accurate device placement than TTE guidance (91% vs 30% in ideal position), similar to results reported with implantation of the Clamshell occluding device with TEE guidance (72% in ideal positiong). Because patient allocation to TTE and TEE was not random, we cannot statistically exclude the possibility that the differences observed are due to selection bias. TEE guidance was used in larger patients than TTE (56.6 f 25.6 kg vs 16.2 2 3.5 kg body weight; P < O.OOOl>, although defect diameter by balloon occlusion was no different (14.5 2 5.0 mm vs 14.1 2 3.1 mm). Nevertheless, we have been impressed that TEE provides more precise, real-time feedback regarding device position than does TTE, which facilitates adjustment of the delivery system until device position is optimal. TEE guidance can be used during fluoroscopy without irradiating the echocardiographer, and does not suffer the degradation of echocardiographic windows commonly experienced when patients are positioned for cardiac catheterization. Because of the time period during which this study was performed, TEE was not available for our smaller patients. With the development of smaller probes, we have used TEE guidance exclusively since 1993, with similar results in small patients.
Ideal device position was associated with fewer potentially significant residual shunts, probably due to better occluder position against the atrial septum, and with fewer instances of unbuttoning, possibly due to less tension on the buttoning apparatus when the occluder does not protrude through the defect. By definition, no patient with ideal device position had impingement of the device on the atrioventricular valve apparatus. Achievement of ideal device position was associated with fewer clinical complications, regardless of the mode of echocardiographic guidance used, but the use of TEE guidance was strongly associated with achievement of ideal device position. Ideal device position therefore appears to be a clinically worthwhile goal. We recommend use of TEE guidance during implantation of the buttoned device in order to enhance the likelihood of achieving ideal device position.
